Tech Company Financing Transactions
New Haven Pharmaceuticals Funding Round
On 10/4/2012, New Haven Pharmaceuticals received $6.5 million in funding from private investors.
Transaction Overview
Company Name
Announced On
10/4/2012
Transaction Type
Venture Equity
Amount
$6,490,773
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
116 Washington Ave. 4th Floor
North Haven, CT 06473
USA
North Haven, CT 06473
USA
Phone
Website
Email Address
Overview
New Haven Pharmaceuticals, Inc. (NHP) develops proprietary, controlled release specialty pharmaceuticals based on approved or GRAS active pharmaceutical ingredients for use in new therapeutic indications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Harry Penner
Chief Executive Officer
Patrick Fourteau
Chief Financial Officer
Michael Milligan
Chief Information Officer
Kimberly Wehger
Chief Scientific Officer
Jeff Patrick
VP - Operations
Larry Dillaha
VP - Regulatory Affairs
Suzanne LoGalbo
Browse more venture capital transactions:
Prev: 10/4/2012: NGDATA venture capital transaction
Next: 10/4/2012: Clear Energy Systems venture capital transaction
Share this article
Where The Data Comes From
We document all VC transactions involving tech companies. VC investment data records reported here are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs